First-line treatment with sunvozertinib significantly prolongs PFS compared to chemotherapy in advanced or metastatic NSCLC with EGFR insertions.

Adding chiauranib to weekly paclitaxel improves PFS, but not OS, in patients with platinum-resistant or refractory ovarian cancer.

Investigators sought to determine whether adjuvant radiotherapy improved locoregional control following chemotherapy and radical cystectomy for patients with high-risk muscle-invasive bladder cancer.

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has fired two key leaders of the task force that sets insurance coverage rules. Dr John Wong, a professor at Tufts University School of ...

Increased cancer mortality seen in association with residential exposure and occupational exposure to coal operations ...

Oncology experts from all over the world will discuss the latest developments in care. The American Society of Clinical ...

In this analysis, researchers evaluated data from a subgroup of US patients enrolled in the phase 2 MagnetisMM‐3 study.

Researchers sought to compare the safety and effectiveness of zanubrutinib and ibrutinib in routine clinical practice.

In this study, researchers evaluated the safety, immunogenicity, and preliminary clinical activity of GNOS-PV01 monotherapy in MGMT-unmethylated glioblastoma.

Researchers evaluated the prognostic value of 1-year tumor volume regression in patients with uveal melanoma treated with plaque brachytherapy.

Dr Janice Mehnert discusses gender disparity in clinical trial leadership and why it is important to have diversity in clinical research.

Researchers explored barriers to colorectal cancer screening uptake in adults aged 45 to 75 years and eligible for colorectal cancer screening.